[Ningmitai Capsules combined with doxycycline hydrochloride for Ureaplasma urealyticumpositive chronic prostatitis]
- PMID: 29658257
[Ningmitai Capsules combined with doxycycline hydrochloride for Ureaplasma urealyticumpositive chronic prostatitis]
Abstract
Objective: To investigate the effects of Ningmitai Capsules (NMT) combined with doxycycline hydrochloride (DH) on chronic prostatitis induced by Ureaplasma urealyticum (Uu).
Methods: This randomized controlled trial included 240 male patients with Uupositive chronic prostatitis, treated orally with NMT at 4 capsules tid (n= 35), DH at 100 mg bid (n = 78), and NMT+DH at the corresponding doses (n = 127), respectively, all for 2 successive weeks. At 1 week after drug withdrawl, we conducted routine urine analysis, EPS examination, and drug sensitivity test of the cultured Uu.
Results: The positivetonegative rate of Uu was significantly higher in the NMT+DH group than in the NMT and DH groups (89.0% [113/127] vs 54.3% [19/35] and 71.8% [56/78], P< 0.05), so were the cure rate (25.2% vs 20.0% and 20.5%, P< 0.05) and total effectiveness rate (89.0% vs 54.3% and 71.8%, P< 0.05).
Conclusions: The combination of Ningmitai Capsules and doxycycline hydrochloride is more effective than either Ningmitai Capsules or doxycycline hydrochloride used alone in the treatment of Uupositive chronic prostatitis.
目的: 观察宁泌泰胶囊联合盐酸多西环素片对溶脲脲原体(Uu)引起的慢性前列腺炎的疗效。方法: 采用随机对照研究方法,选取Uu阳性的慢性前列腺炎患者240例,随机分为中药组(35例)、西药组(78例)和联合组(127例),连续用药2周,观察临床疗效。中药组口服宁泌泰胶囊,4粒/次,3次/日;西药组口服盐酸多西环素片,100 mg/次,2次/日;联合组口服宁泌泰胶囊,4粒/次,3次/日,并联用盐酸多西环素片,100 mg/次,2次/日。结果: 中药组、西药组和联合组Uu转阴率分别为54.3%(19/35),71.8%(56/78)和89.0%(113/127),联合组明显高于中、西药组(P均< 0.05)。联合组、西药组和中药组的治愈率分别为25.2%、20.5%和20.0%,总有效率分别为89.0%、71.8%和54.3%,联合组与中药组比较差异具有统计学意义(P < 0.05)。结论: 宁泌泰胶囊联合盐酸多西环素片治疗Uu阳性的慢性前列腺炎比单用宁泌泰胶囊或盐酸多西环素片疗效好。.
Keywords: Ningmitai Capsules; Ureaplasma urealyticum; chronic prostatitis; doxycycline hydrochloride; drug combination.
Similar articles
-
[Zhibai Dihuang Decoction improves sperm mitochondrial permeability transition in rats with ureaplasma urealyticum infection].Zhonghua Nan Ke Xue. 2018 Jun;24(6):540-546. Zhonghua Nan Ke Xue. 2018. PMID: 30173461 Chinese.
-
Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.Chemotherapy. 2006;52(1):9-11. doi: 10.1159/000090234. Epub 2005 Dec 9. Chemotherapy. 2006. PMID: 16340190 Clinical Trial.
-
[Efficacy of traditional Chinese medicine and Western medicine in the treatment of Ureaplasma urealyticun and Chlamydia trachomatis infectious chronic prostatitis (report of 48 cases)].Zhonghua Nan Ke Xue. 2003 Jun;9(3):202-3, 206. Zhonghua Nan Ke Xue. 2003. PMID: 12861836 Chinese.
-
Meta-analysis of the efficacy of Ningmitai capsule on the treatment of chronic prostatitis in China.Medicine (Baltimore). 2018 Aug;97(33):e11840. doi: 10.1097/MD.0000000000011840. Medicine (Baltimore). 2018. PMID: 30113475 Free PMC article. Review.
-
[Ningmitai Capsule for the treatment of andrological diseases: Advances in studies].Zhonghua Nan Ke Xue. 2017 Oct;23(10):933-937. Zhonghua Nan Ke Xue. 2017. PMID: 29727546 Review. Chinese.
Cited by
-
Chinese advances in understanding and managing genitourinary tract infections caused by Mycoplasma genitalium, Mycoplasma hominis, and Ureaplasma urealyticum.Arch Microbiol. 2024 Nov 28;207(1):5. doi: 10.1007/s00203-024-04204-z. Arch Microbiol. 2024. PMID: 39607610 Review.
-
Ningmitai capsule promotes calculi expulsion after RIRS for 10-20-mm upper urinary stones: a multicenter, prospective, randomized controlled trial.Urolithiasis. 2022 Apr;50(2):205-214. doi: 10.1007/s00240-021-01296-w. Epub 2022 Jan 25. Urolithiasis. 2022. PMID: 35075494 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical